Associations of T helper 1, 2, 17 and regulatory T lymphocytes with mortality in severe sepsis

Inflammation Research

Volumn 62, Issue 8, 2013, Pages 751-763

  Wu, Huang Pin ^a,c   Chung, Kong ^a   Lin, Chun Yao ^a   Jiang, Bor Yiing ^a   Chuang, Duen Yau ^b   Liu, Yu Chih ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Mortality; Regulatory T lymphocytes; Severe sepsis; T helper 1 lymphocytes; T helper 17 lymphocytes

Indexed keywords

LEUKOCYTE ANTIGEN;

AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL BLOOD MONONUCLEAR CELL; REGULATORY T LYMPHOCYTE; SEPSIS; SURVIVAL PREDICTION; TH1 CELL; TH17 CELL; TH2 CELL;

AGED; FEMALE; HUMANS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; SEPSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY;

EID: 84880708586     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0630-3     Document Type: Article

References (34)

1. Ferguson NR, Galley HF, Webster NR. T helper cell subset ratios in patients with severe sepsis. Intensive Care Med. 1999;25:106-9. (Pubitemid 29126723)
2. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol. 2007;148:32-46. (Pubitemid 46365005)
3. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-8.
4. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005;6:1219-27. (Pubitemid 43045633)
5. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467-76. (Pubitemid 39370503)
6. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol. 2007;8:345-50. (Pubitemid 46745409)
7. Jordan MA, Baxter AG. The genetics of immunoregulatory T cells. J Autoimmun. 2008;31:237-44.
8. Rudge G, Gleeson PA, van Driel I. Control of immune responses by immunoregulatory T cells. Arch Immunol Ther Exp (Warsz). 2006;54:381-91. (Pubitemid 44968891)
9. + regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol. 2005;174:7141-6. (Pubitemid 40705680)
10. + T regulatory cells. J Immunol. 2007;179:154-61. (Pubitemid 46986529)
11. Russell JA. Management of sepsis. N Engl J Med. 2006;355:1699-713. (Pubitemid 44583960)
12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003;31:1250-6. (Pubitemid 36444440)
13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-29. (Pubitemid 15250137)
14. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
15. +CD25 high T cells are enriched in the tumor and peripheral blood of prostate cancer patients. J Immunol. 2006;177:7398-405. (Pubitemid 44715110)
16. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med. 2006;173:803-10.
17. +CD127-regulatory T cells and inflammatory response and outcome during shock states. Crit Care. 2010;14:R19.
18. Nascimento DC, ves-Filho JC, Sonego F, Fukada SY, Pereira MS, Benjamim C, et al. Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis. Crit Care Med. 2010;38:1718-25.
19. Wu HP, Chen CK, Chung K, Tseng JC, Hua CC, Liu YC, et al. Serial cytokine levels in patients with severe sepsis. Inflamm Res. 2009;57:385-93.
20. Wu HP, Shih CC, Lin CY, Hua CC, Chuang DY. Serial increase of IL-12 response and human leukocyte antigen-DR expression in severe sepsis survivors. Crit Care. 2011;15:R224.
21. + T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol. 2006;177:7155-63. (Pubitemid 44715084)
22. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454-67. (Pubitemid 351471762)
23. Tulic C, Lazic M, Savic E, Popadic D, Djukic J, Spasic D, et al. The preoperative activity of Th1 and Th17 cytokine axes in prediction of sepsis after radical cystectomy. Eur Cytokine Netw. 2011;22:169-74.
24. Hotchkiss RS, Osmon SB, Chang KC, Wagner TH, Coopersmith CM, Karl IE. Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol. 2005;174:5110-8.
25. Martignoni A, Tschop J, Goetzman HS, Choi LG, Reid MD, Johannigman JA, et al. CD4-expressing cells are early mediators of the innate immune system during sepsis. Shock. 2008;29:591-7. (Pubitemid 351544079)
26. Tschaikowsky K, Hedwig-Geissing M, Schiele A, Bremer F, Schywalsky M, Schuttler J. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompatibility leukocyte antigen-DR expression, procalcitonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med. 2002;30:1015-23. (Pubitemid 34508022)
27. Monserrat J, de Pablo PR, Reyes E, Diaz D, Barcenilla H, Zapata MR, et al. Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care. 2009;13:R26.
28. Chen X, Ye J, Ye J. Analysis of peripheral blood lymphocyte subsets and prognosis in patients with septic shock. Microbiol Immunol. 2011;55:736-42.
29. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50. (Pubitemid 36056721)
30. Ozbalkan Z, Aslar AK, Yildiz Y, Aksaray S. Investigation of the course of proinflammatory and anti-inflammatory cytokines after burn sepsis. Int J Clin Pract. 2004;58:125-9. (Pubitemid 38425741)
31. Fernandez-Serrano S, Dorca J, Coromines M, Carratala J, Gudiol F, Manresa F. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia. Clin Diagn Lab Immunol. 2003;10:813-20. (Pubitemid 37129493)
32. Roberts T, Beyers N, Aguirre A, Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J Infect Dis. 2007;195:870-8. (Pubitemid 46363933)
33. Campbell DJ, Ziegler SF. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol. 2007;7:305-10. (Pubitemid 46480960)
34. Morgan ME, van Bilsen JH, Bakker AM, Heemskerk B, Schilham MW, Hartgers FC, et al. Expression of FOXP3 mRNA is not confined to CD4+ CD25+ T regulatory cells in humans. Hum Immunol. 2005;66:13-20. (Pubitemid 40037706)